Health benefits and clinical impact of major nutrient, red yeast rice: A review

Food and Bioprocess Technology

Volumn 3, Issue 3, 2010, Pages 333-339

  Kalaivani, M ^a   Sabitha, R ^a   Kalaiselvan, V ^a   Rajasekaran, A ^a  

^a KMCH COLLEGE OF PHARMACY   (India)

Author keywords

HMG CoA reductase inhibitors; Hypolipidemic; Monascus purpureus; Osteoporosis; Red yeast rice

Indexed keywords

ANTIOXIDANT PROPERTIES; CARDIOVASCULAR DISEASE; HEALTH BENEFITS; HMG-COA REDUCTASE INHIBITOR; HUMAN BEING; HYPOLIPIDEMIC; MONACOLINS; MONASCUS PURPUREUS; NATURAL FOOD; RED YEAST RICE; SCIENTIFIC EVIDENCE; UNSATURATED FATTY ACIDS;

CHEMICAL VAPOR DEPOSITION; FATTY ACIDS;

YEAST;

MONASCUS; MONASCUS PURPUREUS;

EID: 77952957177     PISSN: 19355130     EISSN: 19355149     Source Type: Journal    
DOI: 10.1007/s11947-009-0197-8     Document Type: Review

References (65)

1. Agarwal, B., Halmo, B., Feoktistov, A. S., Protiva, P., Ramey, W. G., Chen, M., et al. (2002). Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis, 23, 521-528. doi: 10. 1093/carcin/23. 3. 521.
2. Bau, Y. S. (1977). Pigmentation and antibacterial activity of fas neutron and X-ray induced strains of Monascus purpereus. Plant Physiology, 60, 578-581. doi: 10. 1104/pp. 60. 4. 578.
3. Bibhu Prasad Panda, Saleem Javed, Mohammad Ali (2008) Optimization of fermentation parameters for higher lovastatin production in red mold rice through co-culture of Monascus purpureus and Monascus ruber. Food and bioprocess technology, doi: 10. 1007/s 11947-008-0072-z.
4. Bobek, P., Ozdín, L., & Galbavý, S. (1998). Dose- and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition, 14(3), 282-286. doi: 10. 1016/S0899-9007(97)00471-1.
5. Buchwald, H. (1992). Cholesterol inhibition, cancer, and chemotherapy. Lancet, 339, 1154-1156. doi: 10. 1016/0140-6736(92) 90744-N.
6. Caruso, M. G., Notarnicola, M., Cavallini, A., & Di Leo, A. (2002). 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer. Journal of Gastroenterology, 37, 504-508. doi: 10. 1007/s005350200078.
7. Chang, J. C., Wu, M. C., Liu, I. M., & Cheng, J. T. (2006). Plasma glucose-lowering action of Hon-Chi in streptozotocin-induced diabetic rats. Hormone and Metabolic Research, 38(2), 76-81. doi: 10. 1055/s-2006-925116.
8. Chen, F. C., Manchand, P. S., & Whalley, W. B. (1971). The chemistry of fungi: LXIV. The structure of monascin: the relative stereochemistry of the azaphilones. Journal of the Chemical Society, 21, 3577-3579.
9. Chen, C.-C., & Liu, I.-M. (2006). Release of acetylcholine by Hon-Chi to raise insulin secretion in Wistar rats. Neurosci Lett, 404, 117-21. doi: 10. 1016/j. neulet. 2006. 05. 024.
10. Liao, C.-C., & Huang, C.-L. (2008). Red Yeast Rice for a patient with olanzapine-induced dyslipidemia: a test-and-retest case report. Prog Neuropsychopharmacol Biol Psychiatry, 32, 1340-1. doi: 10. 1016/j. pnpbp. 2008. 02. 014.
11. Endo, A., & Monacolin, K. (1980). A new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. Journal of Antibiotics (Tokyo), 33930, 334-336.
12. Fowell, A. D. G., Robertson, A., & Whalley, W. B. (1956). Monascorubramin. Journal of Chemical Society, 5, 27-35.
13. Gavagan, T. (2002). Cardiovascular disease primary care, 29(2), 323-338.
14. Hadfield, J. R., Holker, J. S. E., & Stanway, D. N. (1967). The biosynthesis of fungal metabolites: Part II. The β-oxo-lactone equivalences in rubropunctatin and monascorubrin. Journal of Chemical Society, 19, 751-755.
15. Heber, D., Yip, I., Ashley, J. M., Elashoff, D. A., Elashoff, R. M., & Go, V. L. (1999). Cholesterol-lowering effects of a proprietary Chinese red yeast rice dietary supplement. American Journal of Clinical Nutrition, 69, 231-236.
16. Heber, D., Lembertas, A., Lu, Q. Y., Bowerman, S., & Go, V. L. W. (2001). An analysis of nice proprietary Chinese Red Yeast Rice dietary supplements: implications of variability in chemical profile and contents. Journal of Alternative & Complementary Medicine, 7, 133-139. doi: 10. 1089/107555301750164181.
17. Hentosh, P., Yuh, S. H., Elson, C. E., & Peffley, D. M. (2001). Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Molecular Carcinogenesis, 32, 154-166. doi: 10. 1002/mc. 1074.
18. Hong, M. Y., Seeram, N. P., Zhang, Y., & Heber, D. (2008). Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells. Journal of Nutritional Biochemistry, 19, 448-458.
19. Huang, C. F., Li, T. C., Lin, C. C., Liu, C. S., Shih, H. C., & Lai, M. M. (2007). Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients. European J Cardiovasc Prev Rehabilation, 14(3), 438-440. doi: 10. 1097/HJR. 0b013e32801da137.
20. Huang, Z., Xu, Y., Li, L., & Li, Y. (2008). Two new Monascus metabolites with strong blue fluorescence isolated from red yeast rice. Journal of Agricultural and Food Chemistry, 56(1), 112-118. doi: 10. 1021/jf072985a.
21. Jeon, T., Hwang, S. G., Hirai, S., Matsui, T., Yano, H., Kawada, T., et al. (2004). Red yeast rice extracts suppress adipogenesis by down- regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sciences, 75(26), 3195-3203. doi: 10. 1016/j. lfs. 2004. 06. 012.
22. Journoud, M., & Jones, P. J. H. (2004). Red yeast rice: a new hypolipidemic drug. Life Sciences, 74, 2675-2683. doi: 10. 1016/j. lfs. 2003. 10. 018.
23. Kane, G. C., & Lipsky, J. J. (2000). Drug-grapefruit juice interactions. Mayo Clinic Proceedings, 75(9), 933-942. doi: 10. 4065/75. 9. 933.
24. Keithley, J. K., Swanson, B., Sha, B. E., Zeller, J. M., Kessler, H. A., & Smith, K. Y. (2002). A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition, 18(2), 201-204. doi: 10. 1016/S0899-9007(01)00688-8.
25. Kim, C., Jung, H., Kim, Y. O., & Shin, C. S. (2006). Antimicrobial activities of amino acid derivatives of Monascus pigments. FEMS (Federation of European Microbiological Societies) Microbiology Letters, 264, 117-124. doi: 10. 1111/j. 1574-6968. 2006. 00451. x.
26. Kuromo, M., Nakanishi, K., Shindo, K., & Tada, M. (1963). Biosynthesis of monascorubrin and monascoflavin. Chemical Pharmaceutical Bulletin (Tokyo), 11, 358-362.
27. Lee, C. L., Chen, W. P., Wang, J. J., & Pan, T. M. (2007a). A simple and rapid approach for removing citrinin while retaining monacolin K in red mold rice. Journal of Agricultural and Food Chemistry, 55(26), 11101-11108. doi: 10. 1021/jf071640p.
28. Lee, C. L., Hung, H. K., Wang, J. J., & Pan, T. M. (2007b). Improving the ratio of monacolin K to citrinin production of Monascus purpureus NTU 568 under dioscorea medium through the mediation of pH value and ethanol addition. Journal of Agricultural and Food Chemistry, 55(16), 6493-6502. doi: 10. 1021/jf0711946.
29. Lee, C. L., Kuo, T. F., Wang, J. J., & Pan, T. M. (2007c). Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. Journal of Neuroscience Research, 85(14), 3171-3182. doi: 10. 1002/jnr. 21428.
30. Lee, C. L., Tsai, T. Y., Wang, J. J., & Pan, T. M. (2006). In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Applied Microbiology and Biotechnology, 705, 533-540. doi: 10. 1007/s00253-005-0137-0.
31. Li, Z., Seeram, N. P., Lee, R., Thames, G., Minutti, C., Wang, H. J., et al. (2005). Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers. Journal of Alternative & Complementary Medicine, 11(6), 1031-1038. doi: 10. 1089/acm. 2005. 11. 1031.
32. Lin, C. C., Li, T. C., & Lai, M. M. (2005). Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. European Journal of Endocrinology, 153, 679-686. doi: 10. 1530/eje. 1. 02012.
33. Lin, W. Y., Song, C. Y., & Pan, T. M. (2006). Proteomic analysis of Caco-2 cells treated with monacolin K. Journal of Agricultural and Food Chemistry, 54, 6192-6200. doi: 10. 1021/jf061060c.
34. Lin, C. P., Chen, Y. H., Chen, J. W., Leu, H. B., Liu, T. Z., Liu, P. L., et al. (2008). Cholestin (Monascus purpureus rice) inhibits homocysteine- induced reactive oxygen species generation, nuclear factor- kappa B activation and vascular cell adhesion molecule-1 expression in human aortic endothelial cells. Journal of Biomedical Science, 15(2), 183-196. doi: 10. 1007/s11373-007-9212-0.
35. Liu, L., Zhao, S. P., Cheng, Y. C., & Li, Y. L. (2003). Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clinical Chemistry, 49(8), 1347-1352. doi: 10. 1373/49. 8. 1347.
36. Liu, J., Zhang, J., Shi, Y., Grimsgaard, S., Alraek, T., & Fonnebo, V. (2006). Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chinese Medicine, 1, 4.
37. Ma, J., Li, Y., Ye, Q., Li, J., & Hua, Y. (2000). Constituents of red yeast rice, a traditional Chinese food and medicine. Journal of Agricultural and Food Chemistry, 48(11), 5220-5225. doi: 10. 1021/jf000338c.
38. Man, R. Y., Lynn, E. G., Cheung, F., & Tsang, P. S. (2002). Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2). Molecular and Cellular Biochemistry, 233(1-2), 153-158.
39. Manchand, P. S., Whally, W. B., & Chen, F. C. (1973). Isolation and structure of ankaflavin. Phytochemistry, 12, 2531-2532. doi: 10. 1016/0031-9422(73) 80470-4.
40. Martinkova, L., Patakova-Juzlova, P., Krent, V., Kucerova, Z., Havlicek, V., & Olsovsky, P. (1999). Biological activities of oligoketide pigments of Monascus purpureus. Food Additives and Contaminants, 16, 15-24. doi: 10. 1080/026520399284280.
41. Moghadasian, M. H., & Frohlich, J. J. (1999). Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. American Journal of Medicine, 107(6), 588-594. doi: 10. 1016/S0002-9343(99)00285-5.
42. Mueller, P. S. (2006). Symptomatic myopathy due to red yeast rice. Annals of Internal Medicine, 145, 474-475.
43. Notarnicola, M., Messa, C., Pricci, M., Guerra, V., Altomare, D. F., Montemurro, S., et al. (2004). Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Research, 24, 3837-3842.
44. Palo, M. A., Vidal-Adeva, L., Maceda, L. M. (1960). A study on ang-kak and its production. Philippine Journal of Science, 89, 1-19.
45. Plat, J., & Mensink, R. P. (2001). Effects of plant sterols and stanols on lipid metabolism and cardiovascular risk. Nutrition and Metabolism Cardiovascular Diseases, 11(1), 31-40.
46. Poynter, J. N., Gruber, S. B., Higgins, P. D., Almog, R., Bonner, J. D., & Rennert, H. S. (2005). Statins and the risk of colorectal cancer. New England Journal of Medicine, 352, 2184-2192. doi: 10. 1056/NEJMoa043792.
47. Prasad, G. V., Wong, T., Meliton, G., & Bhaloo, S. (2002). Rhabdomyolysis due to red Yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation., 74, 1200-1201. doi: 10. 1097/00007890-200210270-00028.
48. Qin, S., Zhang, W., Qi, P., Zhao, M., Dong, Z., Li, Y., et al. (1998). Taxonomic investigation of Monascus purpureus 94-25 strain. Journal of Culture Collections, 2, 1997-1998.
49. Ricky, W. K., & Bakr, R. (2008). Chinese red yeast rice (Monascus pupureus fermented-rice) promotes bone formation. Chinese Medicine, 3, 4. doi: 10. 1186/1749-8546-3-4.
50. Smith, D. J., & Olive, K. E. (2003). Chinese red rice-induced myopathy. Southern Medical Journal, 96, 1265-1267. doi: 10. 1097/01. SMJ. 0000100117. 79718. DC.
51. Ukomadu, C., & Dutta, A. (2003). p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclindependent kinases. Journal of Biological Chemistry, 278, 43586-43594. doi: 10. 1074/jbc. M307194200.
52. Venkateshwar, R., Polsani, M. D., Peter, H., Jones, M. D., Christie, M., Ballantyne, M. D., et al. (2008). A case report of myopathy from consumption of red yeast rice. Journal of Clinical Lipidology, 2, 60-62. doi: 10. 1016/j. jacl. 2007. 12. 005.
53. Vercelli, L., Mongini, T., Olivero, N., Rodolico, C., Musumeci, O., & Palmucci, L. (2006). Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. Journal of the American Geriatrics Society, 54(4), 718-720. doi: 10. 1111/j. 1532-5415. 2006. 00668_7. x.
54. Wang, T. H., & Lin, T. F. (2007). Monascus Rice products. Advances in Food and Nutrition Research, 53, 123-159. doi: 10. 1016/S1043-4526(07) 53004-4.
55. Wang, J., Lu, Z., Chi, J., Wang, W., Su, M., Kou, W., et al. (1997). Multicenter clinical trial of the serum lipid-lowering effects of a monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Current Therapeutic Research, 58(12), 964-978. doi: 10. 1016/S0011-393X(97)80063-X.
56. Wang, W. H., Zhang, H., Yu, Y. L., Ge, Z., Xue, C., & Zhang, P. (2004). Intervention of xuezhikang on patients of acute coronary syndrome with different levels of blood lipids. Zhongguo Zhong Xi Yi Jie He Za Zhi, 24(12), 1073-1076.
57. Wei, W., Li, C., Wang, Y., Su, H., Zhu, J., & Kritchevsky, D. (2003). Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. Journal of Nutritional Biochemistry, 14(6), 314-318. doi: 10. 1016/S0955-2863(03)00051-2.
58. Wild, D., Toth, G., & Humpf, H. U. (2002). New monascus metabolite isolated from red yeast rice (angkak, red koji). Journal of Agricultural and Food Chemistry, 14, 3999-4002. doi: 10. 1021/jf020023s.
59. Wong, H. C., & Bau, Y. S. (1977). Pigmentation and antibacterial activity of fast neutron and X-ray induced strains of Monascus purpureus Went. Plant Physiology, 60, 578-581. doi: 10. 1104/pp. 60. 4. 578.
60. Wong, H. C., & Koehler, P. E. (1981). Production and isolation of an antibiotic from Monascus purpureus and its relationship to pigment production. Journal of Food Science, 46, 589-592. doi: 10. 1111/j. 1365-2621. 1981. tb04917. x.
61. Yasukawa, K., Takahashi, M., Natori, S., Kawai, K., Yamazaki, M., Takeuchi, M., et al. (1994). Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol- 13-acetate in two-stage carcinogenesis in mice. Oncology, 51, 108-112.
62. Yasukawa, K., Takahashi, M., Yamanouchi, S., & Takido, M. (1996). Inhibitory effect of oral administration of Monascus pigment on tumor promotion in two-stage carcinogenesis in mouse skin. Oncology, 53, 247-249.
63. Yong-Guo, L. I., Zhang, F., Zheng-Tao, W., & Zhi-Bi, H. (2004). Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 35, 1101-1112. doi: 10. 1016/j. jpba. 2004. 04. 004.
64. Zhao, S. P., Liu, L., Cheng, Y. C., & Li, Y. L. (2003). Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis, 168(2), 375-380. doi: 10. 1016/S0021-9150(03)00142-4.
65. Zhao, S. P., Liu, L., Cheng, Y. C., Shishehbor, M. H., Liu, M. H., Peng, D. Q., et al. (2004). Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation, 110(8), 915-920. doi: 10. 1161/01. CIR. 0000139985. 81163. CE.